Featured Articles
-
21st Century Manufacturing Of Injectable Pharmaceuticals
5/12/2025
Discover how rising competition, niche patient populations, and evolving therapies are reshaping sterile injectable drug development with cutting-edge technologies.
-
A Shift Towards Biofluorescent Particle Counters In Manufacturing
5/12/2025
Sterility in injectable drug manufacturing is vital for patient safety and efficiency. Discover how biofluorescent particle counters revolutionize contamination control, regulatory compliance, and operational excellence in modern pharma.
-
What Is The Position Of Regulatory Authorities On PUPSIT?
5/2/2025
Implementing PUPSIT and other integrity testing methods is crucial for manufacturers to reduce contamination risks and ensure drug product safety. Learn how your company can adhere to updated regulatory guidelines for sterility.
-
Five Considerations For PUPSIT Implementation
5/2/2025
Pre-use, post-sterilization integrity testing (PUPSIT) is vital for contamination control to ensure the integrity of sterilized equipment before use. Learn how PUPSIT can enhance safety and quality in your protocols.
-
How Robotic Isolator Technology Aligns To Annex 1 Principles
4/28/2025
Robotic gloveless isolators provide exceptional automation to eliminate human intervention and reduce contamination risk. Discover how they ensure compliance with the EU Annex 1 guideline to enhance sterility, precision, and monitoring.
-
Economic Advantage Of Robotic Gloveless Pharmaceutical Isolators
4/28/2025
Are robotic gloveless isolators the key to smarter, safer, scalable solutions? Discover how they can revolutionize aseptic filling by reducing contamination, minimizing waste, and enhancing manufacturing flexibility.
-
Biofluorescent Particle Counters Are Gaining Momentum
4/28/2025
The 2025 BioPhorum report highlights challenges and trends in drug filling operations and how they are advancing towards biofluorescent particle counters. Discover an approach that aligns with industry needs.
-
CDMO Uses Robotic Gloveless Isolator For Advanced Therapeutics
4/28/2025
CDMOs must innovate production architectures to meet the demands of advanced therapeutics to ensure a reliable supply and compliance. Discover how these approaches advance modern medicine and improve patient outcomes.
-
Antibody-Drug Conjugates: Manufacturing Precision Medicines
4/21/2025
The monoclonal antibody intermediate is engineered for precise delivery of the linker-payload complex. Discover how rigorous storage measures ensure its quality, which is crucial for successful conjugation and functionality.
-
Five Habits For Reliable Biomanufacturing
4/15/2025
Implement strategies to reduce unplanned downtime and keep your biomanufacturing on track with a checklist that covers maintenance, monitoring, and contingency planning to enhance reliability and resilience.